
|Articles|May 12, 2004
Pathology review study confirms benefit of immediate hormonal therapy
Immediate hormonal therapy in patients with nodal positive prostate cancerwho have undergone radical prostatectomy and pelvic lymphadenectomy confersa survival advantage over delayed hormonal therapy, according to a centralpathology review study by Edward Messing, MD, professor of urology, andcolleagues at the University of Rochester (NY) School of Medicine and Dentistry.
Advertisement
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Trial to compare 225Ac-PSMA-617 vs 177Lu-PSMA-617 for oligorecurrent prostate cancer
2
Farah Rahman, MD, on monitoring resident wellness using biofeedback
3
Veda Giri, MD, on patient-reported outcomes with prostate cancer genetic testing
4
Pearls & Perspectives: Innovation and Evolving Pathways in Female Pelvic Medicine, with Raveen Syan, MD, FPMRS
5






